Iterum Therapeutics Plc (ITRM)

Jan 08, 2026

Is Iterum Therapeutics plc stock overvalued by current metricsProfit Target & High Return Trade Opportunity Guides - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Will Iterum Therapeutics plc stock benefit from sector rotationInflation Watch & Safe Capital Growth Stock Tips - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Can Iterum Therapeutics plc stock deliver surprise earnings beatWeekly Trade Report & Expert Curated Trade Setup Alerts - ulpravda.ru

Jan 08, 2026

Jan 07, 2026

Why Iterum Therapeutics plc stock remains a top recommendationStock Buyback Updates & Market Monitoring and Alerts - ulpravda.ru

Jan 07, 2026

Jan 06, 2026

Will Iterum Therapeutics plc stock benefit from green energy trends2026 world cup usa national team qualification star players possession football odds analysis analysis - ulpravda.ru

Jan 06, 2026

Dec 23, 2025

Iterum Therapeutics expands market access for ORLYNVAH antibiotic - Investing.com

Dec 23, 2025

Dec 23, 2025

Iterum Therapeutics provides business update - marketscreener.com

Dec 23, 2025

Dec 23, 2025

Iterum Therapeutics Provides Business Update - The Manila Times

Dec 23, 2025

Dec 23, 2025

New antibiotic ORLYNVAH could reach 34M+ people pending FDA feedback - Stock Titan

Dec 23, 2025

Dec 19, 2025

Analyzing Iterum Therapeutics (NASDAQ:ITRM) & Savara (NASDAQ:SVRA) - Defense World

Dec 19, 2025

Dec 18, 2025

Why hedge funds are buying Iterum Therapeutics plc stockWeekly Trade Analysis & Capital Efficient Trade Techniques - Улправда

Dec 18, 2025

Dec 17, 2025

Iterum Therapeutics secures major PBM agreement for antibiotic By Investing.com - Investing.com Nigeria

Dec 17, 2025

Dec 17, 2025

Iterum Therapeutics (ITRM) Secures Key PBM Agreement and Expands Patent Portfolio - GuruFocus

Dec 17, 2025

Dec 17, 2025

Iterum Therapeutics secures major PBM agreement for antibiotic - Investing.com

Dec 17, 2025

Dec 17, 2025

New PBM deal could open ORLYNVAH access to 40M more people in 2026 - Stock Titan

Dec 17, 2025

Dec 14, 2025

Iterum Therapeutics faces Nasdaq listing compliance challenge - MSN

Dec 14, 2025

Dec 13, 2025

Iterum Therapeutics Faces Nasdaq Listing Compliance Challenge - The Globe and Mail

Dec 13, 2025

Dec 13, 2025

Iterum Therapeutics receives Nasdaq notice on listing compliance By Investing.com - Investing.com Australia

Dec 13, 2025

Dec 12, 2025

Iterum Therapeutics plc Stock Analysis and ForecastEarnings Forecast Updates & Fast Profit Stock Ideas - earlytimes.in

Dec 12, 2025

Dec 12, 2025

Iterum Therapeutics receives Nasdaq notice on listing compliance - Investing.com

Dec 12, 2025

Dec 12, 2025

Iterum Therapeutics (NASDAQ: ITRM) discloses Nasdaq delisting risk on value, price - Stock Titan

Dec 12, 2025

Dec 09, 2025

Iterum Therapeutics Plc (ITRM) can make a big difference with a little luck - setenews.com

Dec 09, 2025

Dec 06, 2025

Iterum Therapeutics expands reimbursement coverage for ORLYNVAH By Investing.com - Investing.com Nigeria

Dec 06, 2025

Dec 05, 2025

Iterum Therapeutics expands reimbursement coverage for ORLYNVAH - Investing.com

Dec 05, 2025

Dec 05, 2025

ITRM Expands ORLYNVAH Access and Secures Key Medicare Part D Agr - GuruFocus

Dec 05, 2025

Dec 05, 2025

Iterum Therapeutics (Nasdaq: ITRM) inks Medicare Part D deal, EU patent to 2039 - Stock Titan

Dec 05, 2025

Dec 03, 2025

Iterum Therapeutics (ITRM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 03, 2025

Dec 02, 2025

Taking on analysts’ expectations and winning: Iterum Therapeutics Plc (ITRM) - setenews.com

Dec 02, 2025

Nov 25, 2025

Iterum Therapeutics Plc (ITRM) Performance and Fundamentals Dashboard tells a completely different story - Setenews

Nov 25, 2025

Nov 24, 2025

Iterum’s antibiotic ORLYNVAH now available through McKesson By Investing.com - Investing.com Nigeria

Nov 24, 2025

Nov 24, 2025

Iterum’s antibiotic ORLYNVAH now available through McKesson - Investing.com

Nov 24, 2025

Nov 24, 2025

Iterum Therapeutics (ITRM) Expands Product Availability and FDA Clearance - GuruFocus

Nov 24, 2025

Nov 24, 2025

Iterum (NASDAQ: ITRM) Adds McKesson for ORLYNVAH as Sulopenem Disc Gains FDA 510(k) - Stock Titan

Nov 24, 2025

Nov 22, 2025

Q3 2025 Iterum Therapeutics PLC Earnings Call Transcript - GuruFocus

Nov 22, 2025

Nov 21, 2025

Is Iterum Therapeutics plc stock attractive after correctionPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com

Nov 21, 2025

Nov 21, 2025

Why retail investors favor Iterum Therapeutics plc stockJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Can Iterum Therapeutics plc stock maintain operating marginsJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com

Nov 21, 2025

Nov 20, 2025

Iterum Therapeutics director Dunne buys $2,191 in shares By Investing.com - Investing.com Nigeria

Nov 20, 2025

Nov 20, 2025

Dir Dunne Buys 6,000 ($2.2K) Of Iterum Therapeutics PLC [ITRM] - TradingView

Nov 20, 2025

Nov 20, 2025

[Form 4] Iterum Therapeutics plc Insider Trading Activity - Stock Titan

Nov 20, 2025

Nov 20, 2025

Can Iterum Therapeutics plc stock resist market sell offs2025 Big Picture & Fast Gain Swing Alerts - newser.com

Nov 20, 2025